Yüklüyor......
A 10-Month, Open-Label Evaluation of Desvenlafaxine in Outpatients With Major Depressive Disorder
BACKGROUND: The primary objective was to evaluate the long-term safety of desvenlafaxine (administered as desvenlafaxine succinate) during open-label treatment in adult outpatients with a primary DSM-IV diagnosis of major depressive disorder (MDD). METHOD: Depressed adult outpatients (≥ 18 years) wh...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Physicians Postgraduate Press, Inc.
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3184590/ https://ncbi.nlm.nih.gov/pubmed/21977353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/PCC.10m00977blu |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|